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Caco-2 cellsWe performed a screening of miRNAs regulated by dietary lipids in a cellular model of enterocytes, Caco-2 cells.
Our aimwas to describe new lipid-modiﬁedmiRNAswith an implication in lipid homeostasis and cardiovascular
disease [1,2]. For that purpose, we treated differentiated Caco-2 cells with micelles containing the assayed lipids
(cholesterol, conjugated linoleic acid and docosahexaenoic acid) and the screening ofmiRNAswas carried out by
microarray using the μParaﬂo®Microﬂuidic Biochip Technology of LC Sciences (Huston, TX, USA). Experimental
design, microarray description and raw data have been made available in the GEO database with the reference
number of GSE59153. Here we described in detail the experimental design and methods used to obtain the
relative expression data.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Speciﬁcationsrganism/cell
line/tissueHuman Caco-2 cells (enterocytes)x N/A
quencer or
array typeμParaﬂo®Microﬂuidic Biochip Technology of LC Sciences
(Huston, TX, USA)ata format Raw data
xperimental
factorsMicelles containing cholesterol, CLA or DHA vs. empty micellesxperimental
featuresDifferentiated Caco-2 cells were treated with micelles containing
cholesterol (48 h) or micelles containing DHA or CLA (24 h). Con-
trol cells were treated with empty micelles. miRNA-enriched total
RNA was isolated with miRNeasy mini kit (Qiagen, Madrid, Spain).
The expression of miRNAs contained in the miRBase version 17
was analyzed by microarray using the μParaﬂo®Microﬂuidic Bio-
chip Technology of LC Sciences (Huston, TX, USA). Raw data were
normalized, processed and analyzed for statistical signiﬁcance
using t-test and applying multiple testing correctiononsent N/A
mple source
locationN/A1. Direct link to deposited data
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE59153.. This is an open access article under2. Experimental design, materials and methods
For differentiation, Caco-2 cells were plated on polycarbonate
Transwell® ﬁlter inserts of 0.4 μm pore size (Costar, Madrid, Spain) in
6-well plates. Approximately 14 days after conﬂuence cells developmor-
phologic and physiologic characteristics of normal enterocytes [3]. Cho-
lesterol (Chol), CLA and DHA (Sigma, Madrid, Spain) were delivered to
cells as micelles with Lyso-phosphatidylcholine (Lyso-PC; Sigma,
Madrid, Spain) and sodium taurocholate (Tau; Sigma, Madrid, Spain)
[4]. Brieﬂy, Chol (250 μM), CLA (200 μM) or DHA (200 μM)were diluted
in n-hexane (Scharlab; Barcelona, Spain) and dried under a nitrogen
stream. Lyso-PC (200 μM) was also diluted in n-hexane and mixed
with the dried Chol, CLA or DHA, respectively. The mixture was then
dried under a nitrogen stream. Tau (5 mM) was diluted in ethanol 95%
and added to the Lyso-PC/lipid mixture and then evaporated under a ni-
trogen stream. The resulted micelles were diluted in a serum-free medi-
um andmixed vigorously until clear. As control, we used emptymicelles
made with Lyso-PC and Tau. Four control and cholesterol samples, three
DHA samples and two CLA samples were analyzed.
MicroRNA-enriched total RNA was isolated with miRNeasy mini kit
(Qiagen, Madrid, Spain) following manufacturer's instructions. Total
RNA concentration was quantiﬁed with a Nanodrop and the integrity
was conﬁrmed in a 1% agarose gel.
The expression of microRNAs contained in the miRBase version 17
was analyzed by microarray using the μParaﬂo®Microﬂuidic Biochip
Technology of LCsciences (Huston, TX, USA). A total of 1 μg of miRNA-
enriched RNA was used for miRNA microarray. At least three samples of
each condition were analyzed (except for CLA, for which we processedthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Cluster analysis of differentially expressed miRNAs with cholesterol (A), CLA (B) or DHA (C) comparing with empty micelle treated cells. miRNA expression was measured by mi-
croarray and relative expression was calculated as the Log2 (test intensity/control intensity) after background subtraction and LOWESS normalization.
172 L. Daimiel et al. / Genomics Data 5 (2015) 171–172two biological replicates). Raw data corresponding to signal intensity
were corrected for background subtraction and normalized using the
LOWESS (locally weighted regression) method. Relative miRNA levels
were calculated as the Log2 of test intensity/control intensity. Data
were processed to merge replicates and discard discordant replicates
(1-fold Standard deviation). The resulting fold change (FC) was Log2
transformed and analyzed for statistical signiﬁcance using t-test and
applying multiple testing corrections. Microarray data has been submit-
ted to the GEO database complying with the Minimal Information
About a Microarray Experiment (MIAME) guidelines (GSE59153).
Signiﬁcant microRNAs were clustered using average linkage algorithm
and Euclidean distance correlation with TigerMEV software (Boston,
MA, USA) (Fig. 1).
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